Patent Assignment
Reel/Frame 066806/0280
Assignment of Assignor's Interest
Recorded: 2024-03-18
Pages: 14
Assignors
SINHA, UMA
Executed: 2024-02-22
JI, ALAN X.
Executed: 2024-02-23
WONG, PAUL
Executed: 2024-02-29
Assignee
EIDOS THERAPEUTICS, INC.
3160 PORTER DRIVE, SUITE 250, PALO ALTO, CALIFORNIA, 94304
Covered Properties
(2)
Potent Transthyretin (Ttr) Stabilization in Ttr Amyloidosis Patients Receiving Acoramidis
Application:
63/487,801 →
PCT:
PCT/US2024/017918 ↗
Potent Transthyretin (Ttr) Stabilization in Ttr Amyloidosis Patients Receiving Acoramidis
Application:
63/516,757 →
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Jan 17, 2024
From: EIDOS THERAPEUTICS, INC.
To: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
Reel/Frame 066155/0019 →
Security Interest
Jan 17, 2024
From: CALCILYTIX THERAPEUTICS INC.; ADRENAS THERAPEUTICS INC.; PHOENIX TISSUE REPAIR, INC.; NAVIRE PHARMA, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066342/0154 →
Security Interest
Jan 19, 2024
From: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; THERAS, INC.
To: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 066355/0126 →
Release of Security Interest in Patent Collateral
Mar 5, 2025
From: BLUE OWL CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: BRIDGEBIO PHARMA, INC.; QED THERAPEUTICS, INC.; EIDOS THERAPEUTICS, INC.; ML BIO SOLUTIONS INC.
Reel/Frame 070551/0095 →